Is Your Startup Idea Too Early, Or the Wrong Thing?
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Building a company before all the pieces are in place forces calls on timing, focus, and trust. Concurrence co-founder and CEO Ali Khokhar shares how he has made them while building AI for health systems.
Concurrence (formerly Amigo) captures context at the line of care so health systems can learn from every patient they treat. In this episode, Madrona partner Sabrina Albert talks with Ali about the decisions behind it.
What founders can take from this conversation:
1) How to test whether you're early or wrong.
2) When "go narrow and deep" stops working.
2) How to say no to obvious money. Friends pointed him to revenue cycle management because the ROI is clear. Ali passed and says the opportunity costs are already paying dividends.
3) How to sell to skeptical buyers.
4) How to collect net new context.
Founders building ahead of the market, in a regulated industry, or for cautious buyers will find specific decisions on timing, focus, and trust that they can test against their own company.
Transcript: https://www.madrona.com/is-your-startup-idea-too-early-or-the-wrong-thing
Chapters:
00:00 – Introduction
02:52 – Superintelligent Care vs. Medical Superintelligence
04:59 – How to Tell Whether a Startup Is Early or Wrong
06:27 – Why Go-Narrow Startup Advice Becomes a Small Poisonous Pond in Healthcare
08:26 – When a startup has to say no to revenue to accomplish long term product strategy
09:37 – Earning Trust From Skeptical Buyers
11:39 – Why Decades of Healthcare Data Have Not Made Care Better
14:20 – Example of What Concurrence Does
16:06 – Why Amigo Became Concurrence: Expanding a mission
18:02 – What Healthcare Looks Like in Five Years